Zug, Switzerland–Today, PSI CRO, a full-service contract research organization, announced their expansion to India and the appointment of Dr. Radhika Bobba as Regional Director for India and the Asia-Pacific region.
PSI's decision to conduct clinical trials in India was made based on requests from our clients. The PSI Indian base is serving as the hub for continuous expansion into the entire Asia-Pacific region.
PSI has appointed Dr. Radhika Bobba as the Regional Director for India and the Far East. Dr. Bobba, based out of PSI Bangalore, is an MD with 18 years of industry experience in both Contract Research and Pharma. "I am proud to lead the expansion of PSI into the Asia Pac region" says Dr. Bobba. "This expansion is already showing tangible results in strengthening PSI's unique ability to deliver high quality on-time clinical studies world-wide."
About PSI CRO AG: PSI is a privately-held, full-service contract research organization (CRO), operating globally. PSI positions itself as a no-nonsense CRO capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI's global reach supports the operations of clinical trials across multiple countries and continents. PSI has exceptionally high repeat and referral business rates that are indicative of a commitment to be the best CRO in the world as measured by clients and employees. Global headquarters are located in Zug, Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com